For decades, aspirin has been the go‑to drug for preventing heart attacks and strokes. But recent research is turning that assumption on its head. Aspirin has been overtaken by another well-known ...
Ticagrelor (Brilinta; AstraZeneca) doesn’t lessen risks of MI or death and may increase bleeding relative to clopidogrel, according to the results of a study in a real-world ACS population. Across ...
Current evidence seems to indicate that due to individual variability in response to clopidogrel, as many as 30% of patients on maintenance clopidogrel (75 mg/day) may show elevated platelet ...
In patients who develop a hypersensitivity reaction to clopidogrel soon after stenting, a short course of oral corticosteroids usually allows them to continue the antiplatelet therapy without ...
Please provide your email address to receive an email when new articles are posted on . The FDA announced it is conducting an ongoing safety review of clopidogrel bisulfate after receiving reports ...
In January 2008, Dr Steven Steinhubl announced that he was leaving his academic position to join The Medicines Company. Although Steinhubl had no official relationship with the company at the time he ...
Background: Most proton pump inhibitors inhibit the bioactivation of clopidogrel to its active metabolite. The clinical significance of this drug interaction is unknown. Methods: We conducted a ...
Aspirin combined with the antiplatelet drug clopidogrel is no better than aspirin alone for stroke prevention in people with a history of lacunar strokes, and the combination carries a greater risk of ...
Researchers at the European Society of Cardiology Congress reported that the blood thinner clopidogrel should replace aspirin as a routine pill for preventing heart attacks and strokes for people with ...
After a minor stroke or transient ischemic attack, patients with normal vs. impaired renal function treated with ticagrelor plus aspirin had lower risk for stroke at 90 days compared with clopidogrel ...
(HealthDay News) – In patients with stable intermittent claudication due to peripheral arterial disease, low-dose aspirin appears to work as well as clopidogrel when given in conjunction with walking ...
The efficacy of clopidogrel in combination with acetylsalicylic acid (ASA) therapy has been clearly established in well-designed randomized controlled trials that have shown a reduction in recurrent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback